Top Tag

The U.S. Intelligence Community

Merck & Co said Thursday that U.S. regulators have asked for additional data beyond the Phase III study already conducted in order to support potential emergency use authorization of its experimental COVID-19 drug MK-7110.

You may also like

Home Ethos About Contact
Terms Policy GDPR RichTVX
© Saeculum XXI U.S. Intelligence News